Gynevia

Gynevia is a vaginal gel developed by Stragen Pharma Group for the treatment and prevention of bacterial vaginosis (BV). The product is formulated with lactic acid and glycogen to restore and maintain the natural physiological balance of the vaginal environment. Lactic acid acts to immediately lower the vaginal pH, creating an acidic environment that inhibits the growth of pathogenic bacteria. Glycogen serves as a prebiotic nutrient source for beneficial *Lactobacillus* species, promoting their growth and the restoration of a healthy vaginal flora. Gynevia is marketed as a consumer health product and is typically classified as a medical device in various jurisdictions.

Brand names

Gynevia

Other names

Gynevia